Dotmatics

**Dotmatics**
Industry	Life Sciences, Cheminformatics, Bioinformatics;
Founders	Stephen Gallagher BSc PhD (Chief Strategy Officer); Alastair Hill BSc MSc (Distinguished Fellow);
Headquarters	Boston, Massachusetts
Key people	Thomas Swalla (CEO);
Products	Dotmatics Platform; SnapGene; Geneious; GraphPad Prism;
Number of employees	800 (2022);
Website	www.dotmatics.com

Dotmatics is an R&D scientific software company used by scientists in the R&D process. Founded in 2005, the company's primary office is in Boston with 14 offices around the globe. In March 2021, Insightful Science acquired Dotmatics. In April 2022, the two companies consolidated under the Dotmatics brand with Insightful Science CEO Thomas Swalla leading the new Dotmatics. Dotmatics' software is used by 2 million scientists and researchers and 10,000 customers.

Dotmatics offers a cloud-based data management platform to support the R&D process and a series of software applications used by scientists that include GraphPad Prism, SnapGene, Geneious Prime, Geneious Biologics, Lab Archives, OMIQ, Protein Metrics, nQuery, Cytapex Bioinformatics, De Novo, SoftGenetics, and M-Star.

In October 2023, Dotmatics released a multimodal drug discovery platform named Luma. Luma is a low-code SaaS platform that aggregates relevant data across instruments and software into clean data structures for AI and ML-based analysis.

Dotmatics is backed by Insight Partners, a venture capital and private equity firm.

In April 2025, Siemens announced it will acquire Dotmatics for $5.1B from Insight Partners.